Verition Fund Management
THC icon

Verition Fund Management’s Tenet Healthcare THC Stock Holding History

Verition Fund Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
8,000
+4,000
+100% +$735K 0.01% 1247
2026
Q1 		$755K Sell
4,000
-67,100
-94% -$14.1M ﹤0.01% 1425
2025
Q4 		$14.1M Buy
71,100
+13,900
+24% +$2.81M 0.06% 304
2025
Q3 		$11.6M Buy
57,200
+12,400
+28% +$2.2M 0.05% 435
2025
Q2 		$7.88M Buy
44,800
+18,000
+67% +$2.71M 0.04% 682
2025
Q1 		$3.6M Sell
26,800
-32,000
-54% -$4.21M 0.02% 1103
2024
Q4 		$7.42M Buy
58,800
+800
+1% +$119K 0.03% 667
2024
Q3 		$9.64M Buy
58,000
+2,100
+4% +$318K 0.05% 420
2024
Q2 		$7.44M Buy
55,900
+13,400
+32% +$1.61M 0.04% 498
2024
Q1 		$4.47M Buy
+42,500
New +$3.82M 0.03% 751
2022
Q2 		– Sell
-4,600
Closed -$395K – 3024
2022
Q1 		$395K Buy
4,600
+400
+10% +$32.9K ﹤0.01% 2034
2021
Q4 		$343K Buy
+4,200
New +$307K ﹤0.01% 1918

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Verition Fund Management's THC Position: Q2 2026 in Review

Verition Fund Management reduced its Tenet Healthcare (THC) stake by 32% in Q2 2026, selling an estimated $1.5M and leaving 17,325 shares worth $3.24M. The position accounts for 0.02% of the portfolio, ranked #875.

Verition Fund Management first reported a position in THC in Q2 2014 and has held it in 26 quarters since. The position peaked at $10.5M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Verition Fund Management held 17,325 shares of Tenet Healthcare worth $3.24M as of Q2 2026.
  • Verition Fund Management sold 8,141 Tenet Healthcare shares in Q2 2026, an estimated $1.5M.
  • Tenet Healthcare made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #875 holding.
  • Verition Fund Management first reported a position in Tenet Healthcare in Q2 2014 and has held it in 26 quarters since.
  • Verition Fund Management's Tenet Healthcare position peaked at $10.5M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.